Diseases Related Content

The Medicines Manufacturing Innovation Centre (MMIC) has developed a scalable, sustainable and more cost-effective way to manufacture oligonucleotides and treat rare diseases.

Craig Rhodes, EMEA Industry Lead for Artificial Intelligence Healthcare and Life Science at NVIDIA, explores how bovine tuberculosis (bTB) can be monitored and treated more effectively and efficiently using Artificial Intelligence (AI).

Scientist have found that childhood trauma could affect the development and treatment of multiple sclerosis in adulthood.

In a new study, researchers will examine if changing our mealtimes to earlier or later in the day could reduce the risk of developing Type 2 diabetes.

The new UK Rare Diseases Framework sets out to accelerate diagnosis and improve the treatment of rare diseases.

Scientists from Trinity College Dublin have developed a new gene therapy for an eye disease that leads to progressive loss of vision.

Dr Ganesan Baranidharan, consultant in anaesthesia and pain medicine at the Leeds Teaching Hospitals NHS Trust, explains the power of neuromodulation for managing chronic pain and explains why comprehensive evidence is needed.

Prof Monica Di Luca, President, European Brain Council, sheds light on brain conditions, mental and neurological alike, starting with comment on the burdens presented.

New research finds that bleeding and stroke are COVID-19 brain complications that are more frequent in people with diabetes and hypertension.

Dr Katie Howe, Research Communications Manager at the MS Society charts a vision of a world free from the effects of multiple sclerosis.

Mhairi Brown, Policy and Public Affairs Manager for Action on Salt, stresses the need for Public Health England to implement a strict and ambitious salt reduction policy.

A study by the Bloomberg School of Public Health found that severe COVID-19 patients can produce strong antibodies for vaccine testing - especially the older male population.

Ann G. Matthysse, Professor of Biology from The University of North Carolina at Chapel Hill provides an informative introduction to E. coli and diarrheal disease.

Here, Professor Gerald Misinzo and Professor Mark Rweyemamu discuss the potential of the RSIF-PASET Programme.

Steve Jones, President of EU-IPFF and Chair, Action for Pulmonary Fibrosis in the UK describes the connection between COVID-19 and pulmonary fibrosis.

Researchers from the University of Western Australia have found that the venom of honeybees can destroy aggressive breast cancer cells in a lab setting.

Here, we discover why Gendius’ remote management technology, Intellin®, is poised to transform the way that we manage long-term health conditions including diabetes.

Lancaster University researchers suggest that the UK government should work with a deeper understanding of public priorities for track and trace.

According to a new study, cinnamon improves blood sugar control in people with prediabetes and could prevent type 2 diabetes.

Mina Khan, Pharmacist, explores what naturally occurring ingredients are clinically associated with lowering blood sugar.